Bayer Beat Expectations in 4Q; Guides for Increased Earnings, Sales in 2022
March 01 2022 - 2:29AM
Dow Jones News
By Cecilia Butini
Bayer AG on Tuesday posted earnings and sales that beat
consensus expectations, and guided for increased earnings and sales
in the year ahead.
The German pharmaceutical-and-agricultural company reported net
profit of 1.16 billion euros ($1.30 billion) for the last quarter
of the year, up from EUR308 million in the same quarter the year
prior and beating analysts' expectations of EUR731 million.
Earnings before interest, taxes, depreciation and amortization
before special items came in at EUR2.40 billion, also up from the
previous year, when it was EUR2.39 billion.
Sales grew to EUR11.12 billion from EUR10 billion the year
prior, beating consensus expectations of EUR10.47 billion.
Looking ahead, the company said it expects to significantly
increase sales, earnings and free cash flow in 2022. Sales are
expected to be about EUR46 billion in the year ahead, while Ebitda
before special items should be about EUR12 billion, Bayer said.
Core earnings per share are expected to be about EUR7, while
free cash flow is seen at about EUR2 billion to EUR2.5 billion,
after deducting settlement payments.
Bayer said it would propose to maintain its dividend unchanged
to EUR2.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
March 01, 2022 02:14 ET (07:14 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Historical Stock Chart
From Apr 2023 to Apr 2024